相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol-Inducible Cytochrome P450-2E1-Mediated Oxidative and Nitrative Stress
Young-Eun Cho et al.
HEPATOLOGY (2021)
Hybrid Graphene-Gold Nanoparticle-Based Nucleic Acid Conjugates for Cancer-Specific Multimodal Imaging and Combined Therapeutics
Letao Yang et al.
ADVANCED FUNCTIONAL MATERIALS (2021)
Controlled Synthesis and Surface Engineering of Janus Chitosan-Gold Nanoparticles for Photoacoustic Imaging-Guided Synergistic Gene/Photothermal Therapy
Xiaoguang Dai et al.
SMALL (2021)
Iron oxide nanoparticles aggravate hepatic steatosis and liver injury in nonalcoholic fatty liver disease through BMP-SMAD-mediated hepatic iron overload
Meilin Zhu et al.
NANOTOXICOLOGY (2021)
PEI modified orange emissive carbon dots with excitation-independent fluorescence emission for cellular imaging and siRNA delivery
Rui Li et al.
CARBON (2021)
The Role of Senescence in the Development of Nonalcoholic Fatty Liver Disease and Progression to Nonalcoholic Steatohepatitis
Alkistis-Maria Papatheodoridi et al.
HEPATOLOGY (2020)
Nanomaterials for Nanotheranostics: Tuning Their Properties According to Disease Needs
Xin Yi Wong et al.
ACS NANO (2020)
Drug-drug-gene interactions and adverse drug reactions
Mustafa Adnan Malki et al.
PHARMACOGENOMICS JOURNAL (2020)
Ribbon of DNA Lattice on Gold Nanoparticles for Selective Drug Delivery to Cancer Cells
Shuxin Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Surface chemistry governs the sub-organ transfer, clearance and toxicity of functional gold nanoparticles in the liver and kidney
Xue Li et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver Disease
Ruifang Zhao et al.
FRONTIERS IN CHEMISTRY (2020)
Gold Nanoparticle Promoted Formation and Biological Properties of Injectable Hydrogels
Bhingaradiya Nutan et al.
BIOMACROMOLECULES (2020)
Accessing Intracellular Targets throuch Nanocarrier-Mediated Cytosolic Protein Delivery
Ritabrita Goswami et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Selective inhibition of CBP/p300 HAT by A-485 results in suppression of lipogenesis and hepatic gluconeogenesis
Feiye Zhou et al.
CELL DEATH & DISEASE (2020)
Advances in Gold Nanoparticle-Based Combined Cancer Therapy
Kyle Bromma et al.
NANOMATERIALS (2020)
Hepatic impacts of gold nanoparticles with different surface coatings as revealed by assessing the hepatic drug-metabolizing enzyme and lipid homeostasis in mice
Shuang Zhou et al.
NANOIMPACT (2020)
Ultrasmall gold nanoparticles in cancer diagnosis and therapy
Miao Fan et al.
THERANOSTICS (2020)
Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
Na Jia et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2019)
Elimination Pathways of Nanoparticles
Wilson Poon et al.
ACS NANO (2019)
Quantitative Proteomic Analysis Reveals the Sites Related to Acetylation and Mechanism of ACY-1215 in Acute Liver Failure Mice
Wen-bin Zhang et al.
FRONTIERS IN PHARMACOLOGY (2019)
Clinical Aspects of Transporter-Mediated Drug-Drug Interactions
Arne Gessner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Konstantin Kazankov et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Endosomal Size and Membrane Leakiness Influence Proton Sponge-Based Rupture of Endosomal Vesicles
Lotte M. P. Vermeulen et al.
ACS NANO (2018)
DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease
Hanqing Chen et al.
HEPATOLOGY (2018)
Highly Efficient Intracellular Protein Delivery by Cationic Polyethyleneimine-Modified Gelatin Nanoparticles
Ming-Ju Chou et al.
MATERIALS (2018)
Polyethyleneimine-Coated Manganese Oxide Nanoparticles for Targeted Tumor PET/MR Imaging
Jingyi Zhu et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Challenges in realizing selectivity for nanoparticle biodistribution and clearance: lessons from gold nanoparticles
Desiree Van Haute et al.
THERAPEUTIC DELIVERY (2017)
Phenotype Determines Nanoparticle Uptake by Human Macrophages from Liver and Blood
Sonya A. MacParland et al.
ACS NANO (2017)
Drug Metabolism in the Liver
Omar Abdulhameed Almazroo et al.
CLINICS IN LIVER DISEASE (2017)
Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination
Yi-Nan Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Mechanism of hard-nanomaterial clearance by the liver
Kim M. Tsoi et al.
NATURE MATERIALS (2016)
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Daniel Bobo et al.
PHARMACEUTICAL RESEARCH (2016)
Sustained Delivery Growth Factors with Polyethyleneimine-Modified Nanoparticles Promote Embryonic Stem Cells Differentiation and Liver Regeneration
Meiyan Wang et al.
ADVANCED SCIENCE (2016)
Drug-induced liver injury: Interactions between drug properties and host factors
Minjun Chen et al.
JOURNAL OF HEPATOLOGY (2015)
Drug-induced Acute Liver Failure
William M. Lee
CLINICS IN LIVER DISEASE (2013)
The Possible Proton Sponge Effect of Polyethylenimine (PEI) Does Not Include Change in Lysosomal pH
Rikke V. Benjaminsen et al.
MOLECULAR THERAPY (2013)
Role of Fructose-Containing Sugars in the Epidemics of Obesity and Metabolic Syndrome
Kimber L. Stanhope
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Transporter-Mediated Drug-Drug Interactions
L. Zhang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Gold Nanoparticles Capped with Polyethyleneimine for Enhanced siRNA Delivery
Wen-Jing Song et al.
SMALL (2010)
Polyethyleneimine Coating Enhances the Cellular Uptake of Mesoporous Silica Nanoparticles and Allows Safe Delivery of siRNA and DNA Constructs
Tian Xia et al.
ACS NANO (2009)